Edition:
United States

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

108.87USD
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
$108.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
174,735
52-wk High
$132.95
52-wk Low
$67.81

Select another date:

Thu, Oct 27 2016

BRIEF-Abiomed Q2 revenue of $103 million, up 35 pct over prior year

* Abiomed announces q2 fy 2017 revenue of $103 million, up 35% over prior year

BRIEF-Abiomed receives FDA ide approval for initiation of door to unloading prospective feasibility study

* Abiomed receives fda ide approval for initiation of door to unloading (dtu) prospective feasibility study

BRIEF-Abiomed receives FDA IDE approval for initiation of DTU prospective feasibility study

* Receives FDA IDE approval for initiation of door to unloading (DTU) prospective feasibility study

BRIEF-Abiomed reports Q2 FY 2017 gaap earnings per share $0.20

* Announces Q2 FY 2017 revenue of $103 million, up 35% over prior year

BRIEF-Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare

* Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare

BRIEF-Abiomed reports Q1 gaap earnings per share of $0.29

* Is maintaining its fiscal year guidance for gaap operating margin in range of 18% to 20%

Select another date: